Cleared Traditional

K810727 - AST-UV (PLP-ACTIVATED) DETERMINATION

K810727 is the FDA 510(k) clearance for AST-UV (PLP-ACTIVATED) DETERMINATION by The Dow Chemical Co.. It is a Class 2 Chemistry device (product code CIT) cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K810727 · The Dow Chemical Co. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1981
Decision
14d
Days
Class 2
Risk

K810727 is an FDA 510(k) clearance for the AST-UV (PLP-ACTIVATED) DETERMINATION. Classified as Nadh Oxidation/nad Reduction, Ast/sgot (product code CIT), Class II - Special Controls.

Submitted by The Dow Chemical Co. (Mchenry, US). The FDA issued a Cleared decision on March 31, 1981 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1100 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all The Dow Chemical Co. devices

Submission Details

510(k) Number K810727 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 17, 1981
Decision Date March 31, 1981
Days to Decision 14 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 88d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIT Nadh Oxidation/nad Reduction, Ast/sgot
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIT Nadh Oxidation/nad Reduction, Ast/sgot

All 110
Devices cleared under the same product code (CIT) and FDA review panel - the closest regulatory comparables to K810727.
AST(SGOT) IN VITRO DIAG. REAGENT SET
K813405 · Pointe Scientific, Inc., · Dec 1981
ULTRA ZYME PLUS GOT #64953, 65033 & 34
K812592 · Harleco · Sep 1981
GOT ISOENZYME ASSAY EIKEN KIT
K802447 · Syn-Kit, Inc. · Apr 1981
AST (UV) TEST
K810390 · Boehringer Mannheim Corp. · Feb 1981
CENTRIFICHEM AST/SGOT OPTIMIZED REAGENT
K803216 · Union Carbide Corp. · Jan 1981
DATA-ZYME AST(GOT) PROCEDURE
K801856 · Data Medical Associates, Inc. · Sep 1980